#CannabisStocks: Westleaf (TSXV: $WL.V) (OTCQB:
$WSLFF) Enters into New Partnership for Manufacturing Cannabis Extraction and
Production Facility
CALGARY, ALBERTA - March 20, 2019 (Investorideas.com
Newswire) Westleaf Inc. (TSX-V: WL) (OTCQB:WSLFF) ("Westleaf"), is
pleased to announce it has executed a term sheet with Xabis Inc. (“Xabis”),
whereby Xabis has agreed, subject to execution of a definitive agreement, to
provide expertise to the Company’s Calgary cannabis extraction and production
facility. The facility formerly known as Delta West, will be rebranded The
Plant by Westleaf Labs (“The Plant”) after Westleaf consolidated its interest
in The Plant to 100%. Provided Health Canada issues the applicable license for
The Plant, the extraction and production facility under construction in south
east Calgary is expected to produce cannabis derivative products and, after
legalization of such products which is expected later this year, consumables,
topicals and other cannabis infused products, subject to and in compliance with
provincial and federal regulations.
Read this in full at https://www.investorideas.com/news/2019/cannabis/03201TSXVWL-ProductionFacility.asp
Xabis is a Colorado-based
cannabis processing company which provides turnkey operations for companies in
the mid-stream of the cannabis industry. With more than 150 years of collective
experience, Xabis’s team of PHDs and scientists manage, what in Westleaf’s
view, is the most technically difficult processes in the cannabis life-cycle,
all aspects of the extraction and manufacturing of cannabis infused products.
Highlights
·
Tapping
into Industry Leading Expertise – Xabis is an industry leader in design,
construction and management of cannabis extraction and manufacturing
facilities, as well as product development:
o
Xabis has run
facilities in various states in the US for a total of 8 years of cumulative
operating experience; and
o Xabis has developed more
than two dozen different form factors (delivery systems such as vape pens etc.)
and concentrate types with more than two hundred individual product SKUs,
including oil based oral solutions, gummy edibles, hard pressed tablets, water
soluble powders, oil-based capsules, body melt capsules and suppositories.
·
Focus on High
Margin Products –
Upon legalization of the broader set of derivative cannabis products, Westleaf
believes a diversified offering of derivative cannabis products will account
for the majority of consumer demand. Westleaf is focused on differentiated
product formulations to produce vape cartridges, edibles, beverages, and
topicals to meet this expected demand in accordance with applicable
regulations.
·
Developing
Products for the Global Market – The Plant
is being built to EU Good Manufacturing Process (GMP) specifications to ensure
compliance regulations in Canada (one of the largest emerging cannabis
markets), and for export capabilities. Strategically located in Calgary, the
facility is not only in the largest retail market in the prairies, but also has
easy access to transportation services to the rest of Canada and to global
markets.
·
Scalability – The Plant includes an approximately 60,000
square foot complex with Phase I (~15,000 sq. ft.) designed to include R&D,
processing, extraction, manufacturing and order fulfillment. Construction is
expected to be complete in summer 2019. It is anticipated that the facility
will be capable of producing the full suite of new derivative product lines in
preparation of Health Canada’s anticipated legalization of derivative and
consumable products, expected to occur on October 17, 2019.
·
Multiple Revenue
Streams – The Plant is designed to produce a diversified offering of cannabis
derivative products under Westleaf’s brand portfolio. Additionally, Westleaf
plans to offer white labeling services to produce finished products for third
parties, as well as contract manufacturing services for raw extract and
distillation.
·
Truly Vertically Integrated Company – Westleaf is one of
the few truly vertically integrated companies in the Canadian cannabis
industry, with assets owned and under development across each vertical of the
business, including cultivation, extraction, processing & manufacturing,
distribution and wholly owned retail. Westleaf believes that being vertically
integrated provides significant optionality and defensively positions the
company to protect margins across the life cycle of the industry.
“We are entirely focused
on the plant-to-product portion of the value chain,” explains Dale Zink, CEO of
Xabis. “From the end of the grow to the final processed product shipping out to
the retail store or dispensary, we apply our expertise to help companies create
the industry’s best and most profitable processes and systems.” Zink leads a
group of PHDs with extensive experience in biotechnology and chemical
engineering, including experience in the extraction industry, the
pharmaceutical industry and academia.
The move by Xabis into
the Canadian market under an exclusive relationship with Westleaf is the
company’s first foray into the largest single legalized recreational market.
Xabis has designed, built, and operated facilities in five (5) US states where
medical or recreational cannabis has been legalized.
“This partnership is
another part of the execution on Westleaf’s strategy of becoming a significant
vertically integrated player in the Canadian cannabis industry,” said Scott
Hurd, President and CEO of Westleaf. “We believe a diversified offering of
derivative cannabis products will account for a major shift in consumer demand
once legal. We are positioning to formulate unique, high quality derivative
products and bring in the best minds in the industry to help leverage our
expertise in building and running these types of facilities.”
Artist's rendering of The Plant in SE Calgary.
The Brand Story
The Plant derives its name from the origin story of the
company: a plant is not just a source of life; at Westleaf, it’s our source of
inspiration. Not only nature’s ideal version of growth, to us, it’s also a
place of progress and production. A place to press forward. To build on our
foundation, extract our most potent ideas, and to optimize everything we do.
It’s not where we cultivate, it’s where we innovate. In order to ensure we
provide the absolute best our country has to offer and fulfill our mandate to
be at the forefront of cannabis research, development and technology. This is
our place of constant growth.
About Xabis
Xabis brings scientific discipline,
sound business principles, and professionalism to the cannabis industry by
delivering turnkey processing operations for the commercial scale
transformation of cannabis from plant to product. Xabis is led by seasoned
business professionals and scientific experts, including some of the industry’s
leading chemical and biological PhDs and engineers. For more information, please visit http://www.Xabisinc.com.
About Westleaf Inc.
Westleaf is a
vertically integrated cannabis company focused on innovative retail experiences
and engaging cannabis brands as well as cultivation, production and extraction
of cannabis products. Westleaf is rolling out a national retail footprint for
its retail concept Prairie Records, with stores planned for British
Columbia, Alberta, Saskatchewan and potentially Ontario. The retail concept
leverages the instinctual tie between recreational cannabis and music and
redefines the cannabis purchasing experience. The Company also has two
significant production facilities under construction and scheduled for
completion in 2019. For more information, please visit http://www.westleaf.com or www.prairierecords.ca.
More Information:
Bruce Leslie, VP Corporate Communications
Bruce Leslie, VP Corporate Communications
Bruce.leslie@westleaf.com
403-801-7612
Or
Lauren Steeves, NorthStrategic
Lauren.steeves@northstrategic.com
306-717-3253
Neither TSXV nor its Regulation Services Provider
(as that term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this release
Cautionary Statements
This news release
contains “forward-looking information” and “forward-looking statements” (collectively,
“forward-looking statements”) within the meaning of the applicable Canadian
securities legislation. All statements, other than statements of historical
fact, are forward-looking statements and are based on expectations, estimates
and projections as at the date of this news release. Any statement that
involves discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, assumptions, future events or performance (often but
not always using phrases such as “expects”, or “does not expect”, “is
expected”, “anticipates” or “does not anticipate”, “plans”, “budget”,
“scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of
such words and phrases or stating that certain actions, events or results “may”
or “could”, “would”, “might” or “will” be taken to occur or be achieved) are
not statements of historical fact and may be forward-looking statements. This
news release, forward-looking statements relate, among other things, to: (i)
the execution of a definitive agreement with Xabis; (ii) development of The
Plant facility, the quality of the facility, the products to be produced at the
Facility and the expected opening date thereof; (iii) the legalization of
derivative products and the resulting market therefor; (iv) Westleaf’s ability
to market and sell its products across different markets, including globally;
(v) approval of Health Canada for The Plant; and (v) the business and
operations of Westleaf. Forward-looking statements are necessarily based upon a
number of estimates and assumptions that, while considered reasonable, are
subject to known and unknown risks, uncertainties, and other factors which may
cause the actual results and future events to differ materially from those
expressed or implied by such forward-looking statements. Such factors include,
but are not limited to: general business, economic, competitive, political and
social uncertainties; and the delay or failure to receive board, shareholder,
court or regulatory approvals. There can be no assurance that such statements
will prove to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly, readers
should not place undue reliance on the forward-looking statements and
information contained in this news release. Except as required by law, Westleaf
assume no obligation to update the forward-looking statements of beliefs,
opinions, projections, or other factors, should they change, except as required
by law.
This news is
published on the Investorideas.com Newswire – News that Inspires big ideas
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info:
http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the
Investorideas.com newswire by Westleaf Inc Learn more about costs and our newswire
service https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894 .
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Marijuana / Hemp / Cannabis Stocks at Cannabisinvestorideas.com
and Investorideas.com
Investorideas.com
potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News
and Stocks on the Move
Check out our stock
directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
No comments:
Post a Comment